Therapeutic Advances in Drug Safety

Papers
(The median citation count of Therapeutic Advances in Drug Safety is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews46
Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination21
Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance20
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review20
The danger of diazoxide in the neonatal intensive care unit18
The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and 17
Anticholinergic burden measures and older people’s falls risk: a systematic prognostic review15
Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe14
Pharmacovigilance: reporting requirements throughout a product’s lifecycle14
The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review13
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge13
Systematic review of immunosuppressant guidelines in the COVID-19 pandemic12
Definition of self-medication: a scoping review11
Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes9
Inappropriate medications and physical function: a systematic review9
Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases9
Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis8
Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies8
Drug safety of frequently used drugs and substances for self-medication in COVID-198
Self-medication and the ‘infodemic’ during mandatory preventive isolation due to the COVID-19 pandemic8
Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis8
Safety surveillance and challenges in accelerated COVID-19 vaccine development7
Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials7
Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists7
Trends in potentially inappropriate opioid prescribing and associated risk factors among Korean noncancer patients prescribed non-injectable opioid analgesics6
Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis6
The use of a clinical decision support tool to assess the risk of QT drug–drug interactions in community pharmacies5
Patient harm from cardiovascular medications5
Characteristics of voluntary reporting of adverse drug events related to antipsychotics in Australia: 14-year analysis5
The safety of ceftolozane-tazobactam for the treatment of acute bacterial infections: a systemic review and meta-analysis5
Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages5
Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register5
Impact of national valsartan recalls on Veterans’ outcomes4
Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database4
Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes4
Effectiveness of drug postmarketing all-case surveillance as a safety measure in Japan4
Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-194
Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia4
Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database4
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study4
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community4
Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives4
Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana3
Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey3
Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review3
Neurodevelopmental outcomes in children exposed prenatally to levetiracetam3
Neurocognitive effects associated with proprotein convertase subtilisin-kexin type 9 inhibitor use: a narrative review3
Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS3
Analysis of the nature and contributory factors of medication safety incidents following hospital discharge using National Reporting and Learning System (NRLS) data from England and Wales: a multi-met3
Development of a deprescribing manual for frail older people for use in the COFRAIL study and in primary care3
Motivating deprescribing conversations for patients with Alzheimer’s disease and related dementias: a descriptive study3
Impact of risk communication on patient’s safety during the pandemic3
Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home3
Petroselinum crispum, a commonly consumed food, affects sirolimus level in a renal transplant recipient: a case report2
A survey on self-medication for the prevention or treatment of COVID-19 and distrust in healthcare of veterans in a primary care setting in the United States2
Fansidar drug induces cytotoxicity in some vital tissues in a rat model: combination defensive effect of selenium and zinc capsules2
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature2
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy2
Muscle relaxant use and the associated risk of incident frailty in patients with diabetic kidney disease: a longitudinal cohort study2
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study2
Flow rate accuracy of infusion devices within healthcare settings: a systematic review2
Alkalising agents in urinary tract infections: theoretical contraindications, interactions and synergy2
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data2
Use of an electronic medication management support system in patients with polypharmacy in general practice: study protocol of a quantitative process evaluation of the AdAM trial2
Tramadol-induced hiccups: a case–noncase study in the European pharmacovigilance database2
0.018281936645508